跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HEPES
首页
药物
HEPES
Investigational
Small Molecule
HEPES
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
8
H
18
N
2
O
4
S
CAS 编号
7365-45-9
UNII ID
RWW266YE9I
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ROLE OF N-2-HYDROXY-ETHYL-PIPERAZINE-N'-2-ETHANE SULFONIC ACID (HEPES) IN PAIN CONTROL AND REVERSAL OF DEMYELINIZATION INJURY
EP 3520794 A3
申请人: BESPOKE BIOSCIENCE LLC
优先权: 2009
CN
EP
US
10 件公开
COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS
EP 3603667 A1
申请人: TAKEDA VACCINES INC
优先权: 2013
CN
EP
US
6 件公开
Aptamer based affinity capture methods for the selective enrichment of human immunoglobulin Fc domains
US 11572563 B2
申请人: WATERS TECHNOLOGIES CORP
优先权: 2019
CN
US
4 件公开
Species-Specific Tissue Culture Medium for the Propagation of Cells
US 20260209710 A1
申请人: SYMBIOCELLTECH LLC
优先权: 2022
EP
US
WO
3 件公开
METHOD FOR PREPARING EXOSOMES FROM HUMAN PLATELET
EP 4582535 A1
申请人: AVENTACELL BIOMEDICAL CORP LTD
优先权: 2024
CN
EP
US
3 件公开
STABILIZING THERAPEUTIC PROTEINS WITH PIPERAZIN- OR MORPHOLINE-CONTAINING ZWITTERIONIC BUFFERING SUBSTANCES
EP 4487917 A3
申请人: UNIV MUENCHEN LUDWIG MAXIMILIANS
优先权: 2019
EP
US
3 件公开
Methods of improving protein titer in cell culture
US 12031151 B2
申请人: REGENERON PHARMA
优先权: 2021
CN
US
3 件公开
BUFFER SOLUTION FOR ELECTROPORATION AND A METHOD COMPRISING THE USE OF THE SAME
US 2008145938 A1
申请人: AMAXA AG
优先权: 2007
US
3 件公开
HER2 AFFIBODY 99MTC MARKER COMPOSITION AND APPLICATION THEREOF
US 2024207460 A1
申请人: JIANGSU YUANBEN BIOTECHNOLOGY CO LTD
优先权: 2021
CN
US
2 件公开
COMPOSITION FOR NK CELL CRYOPRESERVATION, AND CRYOPRESERVATION FORMULATION COMPRISING SAME
EP 4338591 A1
申请人: GI CELL INC
优先权: 2021
CN
EP
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈